If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


ACS News

Pharmaceutical Roundtable grants available

by Christiana Briddell, ACS staff
April 26, 2019 | A version of this story appeared in Volume 97, Issue 17


The American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable is seeking submissions from academic institutions for three research grant programs through July 1. The $50,000 Greener Medicinal Chemistry Grant will provide support for up to 1 year toward the development of precious-metal-free cross-coupling methodology applicable to pharmaceutically relevant substrates such as heterocycles.

The roundtable’s Ignition Grant Program has four $25,000 grants available to fund high-risk, high-reward research directions with the potential to advance sustainable solutions for pharma. The goal is for researchers to obtain high-quality preliminary results that they might use to apply for additional funding from traditional funding agencies.

The third grant request is for proposals for research to fill a metrics gap with respect to the various forms of CO2 used in applications ranging from small-scale analytical to large-scale preparative and quality-control-based processes. The results will be used to enhance a greenness calculator for analytical instruments. For this grant, proposals should include a proposed budget for the work.

Since 2007, the Pharmaceutical Roundtable has provided over $2 million in green chemistry research funding. These academic-industry collaborations advance key green chemistry research areas identified by the roundtable’s 28 member companies. To apply for a grant, visit


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.